Table 7.
Distribution and Rank Order of the 15 Most Commonly Reported Pediatric Ventilator-Associated Pneumonia (VAP) Pathogens, 2015–2017
| Pathogen | No. (%) Pathogens | Rank |
|---|---|---|
| Staphylococcus aureus | 47 (22.9) | 1 |
| Pseudomonas aeruginosa | 33 (16.1) | 2 |
| Selected Klebsiella spp | 21 (10.2) | 3 |
| Serratia spp | 17 (8.3) | 4 |
| Haemophilus influenzae | 14 (6.8) | 5 |
| Stenotrophomonas maltophilia | 14 (6.8) | 5 |
| Enterobacter spp | 13 (6.3) | 7 |
| All Streptococcus sppa | 11 (5.4) | 8 |
| Escherichia coli | 8 (3.9) | 9 |
| Acinetobacter spp | 5 (2.4) | 10 |
| Moraxella catarrhalis | 4 (2.0) | 11 |
| All Candida sppb | 3 (1.5) | 12 |
| Burkholderia cepacia | 2 (1.0) | 13 |
| Citrobacter spp | 2 (1.0) | 13 |
| Human respiratory syncytial virus | 2 (1.0) | 13 |
| Other | 9 (4.4) | |
| Total | 205 (100.0) |
Note. Selected Klebsiella spp, K. oxytoca and K. pneumoniae.
The group ‘All Streptococcus spp’ aggregates all members of genus Streptococcus, including those not identified to the species level.
The group ‘Other Candida spp’ combines Candida identified to the species level, excluding C. albicans and C. glabrata, and Candida for which the species was not reported. Candida can be reported to the NHSN as pediatric VAP pathogens when identified in lung tissue or pleural fluid, or in an immunocompromised patient when a matching Candida organism is identified from blood and a lower respiratory tract specimen. More information is available in the NHSN Patient Safety Component Protocol.